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Abstract The pathophysiology of acute coronary syn-
dromes has long been associated with atherosclerotic
plaque rupture. Inflammation, thinning, and disruption of
the fibrous cap have been implicated with the final
processes leading to plaque rupture, but confirmation of
these mechanisms of coronary thrombosis in humans has
been hampered by the lack of imaging methods with
sufficient resolution to resolve fibrous cap characterization
and thickness in vivo. Intravascular optical coherence
tomography (OCT) provides images with micron-level
axial and lateral resolution, enabling detailed visualization
of micro-structural changes of the arterial wall. The present
article provides an overview of the potential role of OCT in
identifying and characterizing fibrous cap morphology,
thickness, and inflammation in human coronary plaques.
Keywords Optical coherence tomography . OCT. Fibrous
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Introduction
Acute coronary thrombosis has been shown to result from
disruption of the protective fibrous cap and exposure of a
prothrombotic necrotic core to the blood stream [1, 2].
Atherosclerotic plaques most likely to rupture have been
characterized as those containing a large lipid necrotic core
covered by a thin fibrous cap, which is infiltrated by
macrophages [3, 4]. The daunting task of identifying the so-
called “vulnerable plaques” before symptoms arise and
prevent subsequent myocardial infarction (MI) or sudden
death has stirred the minds of many clinicians and
scientists. However, it has become clear that our understand-
ing of the pathophysiology of acute coronary syndrome
(ACS) remains incomplete.
Thickness of the fibrous cap has been suggested as a
marker of plaque rupture. Further understanding of the role
of fibrous cap as a risk factor of ACS demands high-
resolution in vivo imaging in humans. The recent introduc-
tion of intravascular optical coherence tomography (OCT),
a new imaging technique that uses near-infrared light to
provide high-resolution (10–15 μm) imaging, makes it
possible to visualize the arterial wall microenvironment [5].
This article provides an overview of the potential role of
intravascular OCT in the characterization of fibrous plaque
morphology, with emphasis on validation studies and
current clinical applications. A brief review of the basic
principles of this novel imaging modality and future
perspectives are also discussed.
The Fibrous Cap
The fibrous cap has been defined as a distinct layer of
connective tissue covering the lipid core of an atheroscle-
rotic plaque, and consists purely of smooth muscle cells in
a collagenous-proteoglycan matrix, with varying degrees of
infiltration by macrophages and lymphocytes [4]. Rupture
of the fibrous cap exposes prothrombotic material, which
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triggers platelet activation, aggregation, thrombin forma-
tion, and ultimately thrombosis. Disruption of the fibrous
cap has been identified in 60% to 75% of pathology
specimens from patients dying of acute coronary thrombo-
sis, followed by plaque erosion (25%–30%), and calcified
nodule (2%–7%) [4, 6, 7]. Transition of “stable plaques” to
plaque rupture has been characterized by the presence of
endothelial denudation with superficial platelet aggregation,
large lipid necrotic core, active inflammation (monocyte/
macrophage infiltration), thinning of the fibrous cap, and
intraplaque hemorrhage [8]. The exact mechanism of
fibrous cap thinning has not been fully elucidated, but
necropsy studies found ruptured plaques to have fibrous
caps <65 μm in thickness [9]. The data come from an ex
vivo morphometric assessment of 41 ruptured plaques, in
which the mean cap thickness was 23±19 μm and 95% of
the caps measured less than 64 μm [9]. The data are
plagued by methodological flaws in measuring the fibrous
cap, a three-dimensional (3-D) structure, in single cross-
sections and by potential histology preparation artifacts,
which inherently leads to shrinkage of the tissue. Impor-
tantly, cause–effect relationships cannot be derived from the
data. Nevertheless, the thin-cap fibroatheroma (TCFA) has
been considered the non-thrombosed lesion that mostly
resembles the ruptured plaque, and has been characterized
by a necrotic core with an overlying thin fibrous cap
(<65 μm) infiltrated by macrophages (>25 cells per
0.3 mm) containing rare smooth muscle cells [3, 4, 7].
Current Imaging Modalities
Angiography
Coronary angiography has long been considered the
“gold standard” method to assess the severity of luminal
narrowing, serving as a diagnostic and decision-making
tool in the catheterization laboratory. It allows for the
assessment of lumen silhouette, but does not provide
information regarding the arterial wall or plaque. Most
acute coronary occlusions occur in “angiographically
normal” segments, and only a minority occur at sites of
severe stenosis [10].
Intravascular Ultrasound
Intravascular ultrasound (IVUS) provides real-time tomo-
graphic cross-sectional images of the coronary vessel wall,
providing valuable insights into quantification and compo-
sition of coronary plaques, such as eccentricity, hypoecho-
genicity, and positive remodeling. Its limited axial
resolution (~200 μm) precludes assessment of the fibrous
caps [11].
Radiofrequency IVUS Data Analysis (Virtual Histology)
Autoregressive spectral analysis of IVUS backscattered
radiofrequency signal allows characterization of different
plaque components. This technique has been coined virtual
histology IVUS (VH-IVUS), although its correlation with
true histology is only marginal [12]. Plaque components are
assigned a color-coded scheme according to tissue ultra-
sound signal properties into four different types of plaque
components [13]. The VH-IVUS proposed definition of
“TCFA” is a scientific misnomer, as neither the fibrous cap
nor its thickness are considered due to limited axial
resolution of the method [14].
Optical Coherence Tomography
Basic Principles
Intravascular OCT is a catheter-based image modality that
produces high-resolution cross-sectional imaging of biologi-
cal tissues by measuring the magnitude and “echo time delay”
of backscattered light, instead of ultrasound. Since the speed
of light (3×108 m/s) is much faster than that of sound
(1,500 m/s), an interferometer is required to measure the
backscattered signal. The interferometer uses a fiberoptic
coupler similar to a beam splitter, which directs half of the
beam to the measurement arm (tissue) and the other half to
the reference arm. The light source used by intravascular
OCT has a near-infrared spectrum, with wavelengths ranging
from 1,250 to 1,350 nm. The axial resolution of current OCT
systems ranges from 10 to 15 μm [5], which allows detailed
visualization of biological structures at a micro-scale level
[5]. Cross-sectional images are created based on a series
of multiple axial scans (A-scans) at different transverse
positions in order to generate a two-dimensional dataset
(B-scan). Newer OCT systems use a fixed mirror with a
variable frequency light source, or “swept-laser,” to
produce known echo delays. This allows the system to
acquire 100 to 200 frames/s with a pullback speed of up
to 40 mm/s, having the potential to scan 4–6 cm length
of a coronary artery in less than 5 s. Importantly, red
blood cells cause significant attenuation of the light
signal, requiring blood to be completely displaced prior
to image acquisition. The high pullback speed eliminates
the need for balloon occlusion to clear the blood, which
is now achieved by a contrast bolus injection [5].
OCT and Fibrous Cap: Identification
Light is absorbed by lipids, leading to a region of low or no
signal, casting the vascular wall beyond in shadow [5].
Identification of the lipid-necrotic core represents a funda-
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mental step toward identifying the fibrous cap. Ability of
OCT to detect lipid-rich plaques has been demonstrated ex
vivo [15]. Three hundred and fifty-seven diseased arterial
segments were examined by histology and OCT image. On
OCT, fibrous tissue appears as homogenous, signal-rich
regions; fibrocalcific or calcific tissue appear as well-
delineated, signal-poor regions with sharp borders; and lipids
are depicted as signal-poor regions with diffuse borders [15].
OCT showed 94% sensitivity and 92% specificity to detect
lipid-rich plaques. Furthermore, others found that lipid
plaques were identified more frequently by OCT compared
with IVUS [16]. The interface between the fibrous tissue and
lipidic necrotic core produces a high superficial backscatter-
ing signal. The combination of a signal-rich band overlying a
signal-poor region produces a unique, distinct signature,
which can be easily identified on OCT images (Fig. 1).
OCT and Fibrous Cap: Measurement
A preclinical validation study assessed the feasibility of
OCT to determine fibrous cap thickness using histology
as the “gold standard” in 35 lipid-rich plaques from 102
coronary arterial segments of 38 human cadavers [17].
Fibrous cap was defined by OCT as the minimum axial
distance from the coronary lumen to the inner border of
the lipid pool, and its thickness was measured at the
thinnest portion in each plaque. The thickness of the
fibrous cap ranged from 10 to 450 μm (mean 138 μm) by
histology and 10 to 430 μm (mean 163 μm) by OCT.
Good correlation (r=0.90, P<0.001) and agreement (mean
difference, -24±44 μm) were observed between the OCT
and histologic measurements, with surprisingly low intra-
observer (13±41 μm) and interobserver (20±59 μm)
variability reported [17].
Culprit lesions of 30 patients with MI were examined
with OCT, IVUS, and angioscopy. OCT was the only
method able to estimate the fibrous cap thickness at 49±
21 μm, using similar methodology as described above. In
addition, the study revealed, for the first time, the ability to
detect fibrous cap erosion in vivo using OCT (23%), but
not by IVUS [18].
Recent OCT studies have revealed that the commonly
used threshold of 65 μm to define a thin fibrous cap




OCT. a, A mild concentric
fibrous plaque, characterized by
homogenous, signal-rich
regions. Lipidic plaques
(b, c, and d) are characterized
by superficial signal-rich region
followed by a drop in signal, as
a result of high backscattering
and attenuation (asterisks). The
fibrous cap can be identified as a
homogeneous signal-rich band
overlying the lipid-rich core. b,
A lipid-rich plaque with thick
cap (cap thickness at the
thinnest part measured 178 μm).
c, A thin-cap fibroatheroma,
defined by a thin-cap (46 μm at
its thinnest part) overlying a
lipid-rich plaque. d, Rupture of
the fibrous cap overlying a
lipid-rich plaque can be
observed
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in nonruptured plaques. In vivo OCT examinations have
shown that fibrous cap thickness varies widely between
ruptured and nonruptured plaques. In a recent clinical study
with 266 patients, the median thinnest cap thickness was
54 μm in ruptured plaques, compared with 80 μm in
nonruptured plaques. The median, most representative cap
thickness was also significantly thinner in the ruptured
plaques (116 vs 182 μm, P=0.01). In 95% of the ruptured
plaques, the thinnest cap thickness and most representative
cap thickness were <80 and <188 μm, respectively. Of
note, the best cutoff for predicting rupture was 151 μm
(OR: 35.6, 95% CI=15.0–84.3, P<0.001) for most repre-
sentative cap thickness [19••].
Fibrous cap thickness has also been observed to vary
according to clinical presentation. Patients with ST eleva-
tion MI (STEMI) showed significantly lower median mean
values of the minimum thickness of the fibrous cap (47 μm)
in comparison to non-ST elevation MI (NSTEMI)
(53.8 μm) and stable angina (102.6 μm) patients (P=
0.034 for all comparisons) [20]. Interestingly, fibrous cap
thickness has also been shown to be thinner in patients
presenting with resting angina (50 μm) in comparison to
patients presenting with angina triggered by exertion
(90 μm) [21••]. In another report comparing culprit lesion
morphologies between STEMI and NSTEMI patients by
OCT, fibrous cap thickness was significantly thinner (55±
20 μm vs 109±55 μm, P<0.001) in STEMI patients.
Importantly, a “proximal-type” rupture of the fibrous cap
was more often seen in STEMI (46% vs 17%, P=0.039),
while “distal-type” aperture was more often observed in
NSTEMI (11% vs 35%, P=0.048), suggesting that longi-
tudinal morphology and location of cap rupture, as
visualized by OCT, may contribute to the variable clinical
presentation of plaque rupture [22•]. Collectively, these
early OCT studies revealed unprecedented features of the
fibrous cap and establish a solid foundation for future
research. However, methodological refinements are still
required to advance our understanding of the pathophysi-
ology of ACS and plaque rupture. The retrospective nature
of these studies, similar to necropsy investigations, pre-
cludes a better assessment of the cause-effect relationship
between fibrous cap thickness and plaque rupture. For
instance, it is impossible to determine cap thickness at the
location of the rupture, limiting assessment to the adjacent
segments of the cap.
Current methodology for determining fibrous cap thick-
ness is derived from histology and relies on manual
measurement at a single point or by averaging multiple
measurements [17, 18], [19••], [20], [22•], [23–25] at
locations presumed, by visual assessment, to be the thinnest
region in a cross-sectional image. However, the fibrous cap
is a dynamic 3-D structure subjected to a variety of
mechanical, biological, chemical, and inflammatory factors
and its thickness varies considerably along the plaque.
Performing random measures in a single or few cross-
sections will likely not capture the complex 3-D nature of
the fibrous cap.
OCT and Fibrous Cap: 3-D Assessment
Our group is working on establishing a 3-D display of
the fibrous cap that allows volumetric quantification of
thickness to overcome these limitations. The ultimate
goal is to have automated identification of lipid plaques
with real-time, comprehensive, and accurate determina-
tion of the morphological features of the fibrous cap,
with minimal requirement for observer interference.
Briefly, after determining the region of interest (lipid-
rich plaque), a computer program automatically segments
the entire extent of the fibrous cap. Cap thickness in
every locus is then quantified with respect to the centroid
of the lumen. A color classification scheme is con-
structed in a 3-D–rendered image, mapping the entire
extent of the fibrous cap in different regions according to
its thickness in red (<65 μm), green (65–150 μm), or
blue (>150 μm) (Fig. 2). Hence, minimal, maximal, and
mean values of the fibrous cap thickness can be deter-
mined along with the quantification of area and volume of
the whole cap. The 3-D display enables a comprehensive
visualization of the longitudinal and circumferential
distribution of the fibrous cap, and identification of
“hotspots” of thin regions.
OCT and Fibrous Cap: Inflammation
The central role of active inflammation in the pathophys-
iology underlying arterial thrombosis has been well
described [26, 27]. Macrophage infiltration of the fibrous
cap of atherosclerotic plaques is thought to weaken the
structural integrity of the cap, predisposing plaques to
rupture [28, 29]. Macrophages/foam cells in atherosclerotic
plaques are relatively large (20–30 μm) and may contain
multiple intracellular, lipid-rich phagolysosomes. It has
been postulated that as a function of their size and the
refractive index difference between the phagolysosomes
and the surrounding intracellular fluid, macrophages may
have a higher OCT signal than the surrounding tissue [30,
31]. A high positive correlation between OCT and
histological measurements of fibrous cap macrophage
density (r=0.84, P<0.0001), and a negative correlation
between OCT and histological measurements of smooth
muscle actin density (r = −0.56, P < 0.005) have been
demonstrated in an ex vivo experiment [30]. Eighty-four
percent of the OCT images depicted signs of macrophage
infiltration at the interface between the cap and the lipid
necrotic core of “vulnerable plaques” [32].
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ACS patients had significantly greater macrophage
density based on OCT parameters, both for fibrous and
lipid-rich plaques (P=0.025 and P=0.002, respectively),
than patients with stable angina [33]. In addition, sites of
plaque rupture demonstrated a greater macrophage density
than nonruptured sites (6.95%±1.60% vs 5.29%±1.17%,
P=0.002). Good correlation between macrophage density
in the fibrous cap and white blood cell count (r=0.483, P<
0.001) has also been described. Both parameters were
associated with lipid-rich plaque and correlated inversely
with fibrous cap thickness (r = −0.547 for macrophage
density and −0.423 for white blood cell count, P<0.015)
[34]. A recent small study with 25 ACS patients demon-
strated that baseline systemic levels of myeloperoxidase
were significantly higher in patients with eroded plaques
than in patients with ruptured plaques (median, 2500 [IQR:
1,415–2,920] ng/mL vs 707 [312–943] ng/mL, P=0.001) as
determined by OCT, although high-sensitivity C-reactive
protein (hs-CRP) levels did not differ significantly (median,
11.3 [1.3–28.5] mg/L vs 3.9 [1.3–17.8] mg/L, P=0.76)
[35•]. Systemic levels of hs-CRP have also been found to
be significantly higher in ACS patients with ≥1 TCFA
detected by OCT in the target vessel, in comparison to non-
TCFA ACS patients [24]. These observations, although
retrospective in nature and preliminary, suggest a preferen-
tial spatial distribution of macrophages in culprit lesions
within the same patient, even in the setting of a generalized
inflammatory process. Whether inflammation preceded the
clinical event (ie, plaque rupture) or it was a consequence
and therefore a marker of disease remains to be demon-
strated. Nevertheless, these findings indicate a potential
clinical role of OCT in identifying inflammation on the
surface of lipid-rich plaques, which could become a new
surrogate of plaque vulnerability.
OCT and Fibrous Cap: Therapeutic Implications
Several IVUS-based studies have been conducted over the
last decade to evaluate the effects of different lipid-lowering
drugs on atheroma size [36, 37]. Although the efficacy of
lowering low-density lipoprotein cholesterol with inhibitors
of hydroxymethylglutaryl-coenzyme A reductase (statins) is
unequivocal, the change in atheroma size promoted by
statins has not been consistent across all IVUS studies [36].
Fig. 2 Volumetric method for quantification of fibrous caps. a, A
two-dimensional cross-section image depicting a lipid-rich plaque
(asterisks). b, After segmenting the entire fibrous cap extension, a
color classification scheme is constructed, mapping the whole fibrous
cap according to the regional thickness in red (< 65 μm), green (65–
150 μm), or blue (> 150 μm). The fibrous cap is segmented in all
frames containing a lipid-rich plaque, allowing for real-time volumet-
ric assessment. c, 3-D rendering reconstruction with fly-through of the
coronary vessel, demonstrating the thickness quantification mapping
of the whole cap. d, Longitudinal view, allowing a broad visualization
of longitudinal and circumferential distribution of the thickness of the
fibrous cap. The thresholds of fibrous cap thickness used in this
representative example were selected according to the current criteria
derived from pathology. However, this novel method allows for
quantification of fibrous caps to move from a binary question to a
continuous variable, changing the concept of finding a single
threshold to predict plaque rupture into a more comprehensive
assessment of this complex and dynamic structure
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The commonly used parameters of changes of total
atheroma volume or percent change of atheroma volume
may be affected by vessel size and remodeling, and the role
of these quantitative variables on the pathophysiology of
ACS remains questionable.
OCT has been recently used to assess the effects of
statins on coronary fibrous cap thickness in ACS patients.
Serial OCT examinations at baseline and 9-month follow-
up revealed that the fibrous cap thickness significantly
increased in both the statin-treated group (P<0.01) and
control group (P<0.01) over time [38]. However, the
degree of increase was significantly greater in the statin-
treated group (188%±64% vs 117%±39%, P<0.01) [39••].
Another study showed that patients previously in use of
statins had a significantly lower frequency of ruptured
culprit plaques than patients not taking statins (8% vs 36%,
P=0.03), with a trend toward an increase in the fibrous cap
thickness (78 vs 49 μm, P=0.07).
Although systemic therapies appear more attractive for
“stabilization” of vulnerable plaques, an interventional
approach applied locally to asymptomatic vulnerable
plaques has been proposed [6, 40]. In the Providing
Regional Observations to Study Predictors of Events in
the Coronary Tree (PROSPECT) trial, the natural history of
coronary atherosclerosis was investigated using multimo-
dality intravascular imaging of the three major coronary
arteries, with patients under optimal medical therapy,
including statins. A VH-IVUS–derived TCFA with a
minimum lumen area ≤4.0 mm2 and a large plaque burden
(≥ 70%) had a likelihood of causing an ischemic event
within 3 years of 17.2%. However, the anticipated high
frequency of acute thrombotic cardiovascular events did not
occur, with only 1% rate of MI and no deaths directly
attributed to nonculprit vessels over 3-year follow-up.
These results suggest that nonculprit, yet obstructive
coronary plaques, are most likely to be associated with
increasing symptoms rather than thrombotic acute events,
with 8.5% of patients presenting with worsening angina and
3.3% with unstable angina [41]. Studies using OCT and
more refined characterization of the plaque, fibrous cap,
and inflammatory process are still pending.
Future Perspectives
Advances in OCT technology may further increase the
anatomical and functional assessment of the fibrous cap.
Interstitial collagen and smooth muscle cells are closely
involved in the biomechanical strength of the fibrous cap,
conferring stability. Polarization-sensitive OCT has proven
capable of measuring birefringence (a material property that
is elevated in tissues such as collagen and smooth muscle
cells). An ex vivo study demonstrated that polarization-
sensitive OCT enables the measurement of birefringence in
plaques and in fibrous caps of necrotic core fibro-
atheromas, with potential to evaluate collagen content,
collagen fiber thickness, and smooth muscle cell density
[42]. Furthermore, nanomedicine is a fast evolving field
and development of nanoparticles targeted against specific
antibodies might allow for an easy way to detect and
quantify macrophage in the fibrous cap by OCT.
Conclusions
Fibrous cap integrity is an important prerequisite for plaque
stability. TCFA is identified, on the basis of several
pathological studies, as the precursor for plaque rupture,
the most common cause of acute coronary thrombosis and
ACS. Evaluation of fibrous cap thickness is critical for
characterization of TCFA. Until recently, accurate assess-
ment of the fibrous cap in vivo was not possible due to the
lack of available imaging modalities with high resolution.
The recently introduced intravascular OCT with micrometer
resolution has proven to be a feasible and reproducible
method to resolve the fibrous cap structural aspects. OCT
may fill an important gap in our knowledge regarding the
true natural history of atherosclerotic plaques, with poten-
tial to increase current in vivo diagnostic capacity of prone-
to-rupture plaques, and assist in the development of specific
preventive and therapeutic approaches.
Disclosure D. Chamié: none; Z. Wang: none; H. Bezerra: honoraria
from St. Jude Medical; A. M. Rollins: none; M. A. Costa: honoraria
from St. Jude Medical.
References
Papers of particular interest, published recently, have been
highlighted as:
• Of importance
•• Of major importance
1. Falk E. Plaque rupture with severe pre-existing stenosis precipi-
tating coronary thrombosis. Characteristics of coronary athero-
sclerotic plaques underlying fatal occlusive thrombi. Br Heart J.
1983;50(2):127–34.
2. Davies MJ, Thomas A. Thrombosis and acute coronary-artery
lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310
(18):1137–40.
3. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the
unstable plaque. Prog Cardiovasc Dis. 2002;44(5):349–56.
4. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden
coronary death: a comprehensive morphological classification
scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol.
2000;20(5):1262–75.
Curr Cardiovasc Imaging Rep (2011) 4:276–283 281
5. Bezerra HG, Costa MA, Guagliumi G, et al. Intracoronary optical
coherence tomography: a comprehensive review clinical and
research applications. JACC Cardiovasc Interv. 2009;2(11):1035–
46.
6. Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment
of the vulnerable human coronary plaque. Heart. 2004;90
(12):1385–91.
7. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the
vulnerable plaque. J Am Coll Cardiol. 2006;47(8 Suppl):C13–18.
8. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage
and progression of coronary atheroma. N Engl J Med. 2003;349
(24):2316–25.
9. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and
plaque morphology in men with coronary disease who died
suddenly. N Engl J Med. 1997;336(18):1276–82.
10. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary
angiography predict the site of a subsequent myocardial infarction
in patients with mild-to-moderate coronary artery disease?
Circulation. 1988;78(5 Pt 1):1157–66.
11. Mintz GS, Nissen SE, Anderson WD, et al. American College of
Cardiology Clinical Expert Consensus Document on Standards for
Acquisition, Measurement and Reporting of Intravascular Ultra-
sound Studies (IVUS). A report of the American College of
Cardiology Task Force on Clinical Expert Consensus Documents.
J Am Coll Cardiol. 2001;37(5):1478–92.
12. Thim T, Hagensen MK, Wallace-Bradley D, et al. Unreliable
assessment of necrotic core by virtual histology intravascular
ultrasound in porcine coronary artery disease. Circ Cardiovasc
Imaging. 2010;3(4):384–91.
13. Nair A, Margolis MP, Kuban BD, Vince DG. Automated coronary
plaque characterisation with intravascular ultrasound backscatter:
ex vivo validation. EuroIntervention. 2007;3(1):113–20.
14. Rodriguez-Granillo GA, Garcia-Garcia HM. Mc Fadden EP, et al.
In vivo intravascular ultrasound-derived thin-cap fibroatheroma
detection using ultrasound radiofrequency data analysis. J Am
Coll Cardiol. 2005;46(11):2038–42.
15. Yabushita H, Bouma BE, Houser SL, et al. Characterization of
human atherosclerosis by optical coherence tomography. Circulation.
2002;106(13):1640–5.
16. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary
atherosclerotic plaques in patients using optical coherence
tomography: comparison with intravascular ultrasound. J Am
Coll Cardiol. 2002;39(4):604–9.
17. Kume T, Akasaka T, Kawamoto T. Measurement of the thickness
of the fibrous cap by optical coherence tomography. Am Heart J.
2006;152(4):755. e751–754.
18. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit
lesion morphology in acute myocardial infarction: ability of
optical coherence tomography compared with intravascular
ultrasound and coronary angioscopy. J Am Coll Cardiol.
2007;50(10):933–9.
19. ••Yonetsu T, Kakuta T, Lee T, et al. In vivo critical fibrous cap
thickness for rupture-prone coronary plaques assessed by optical
coherence tomography. Eur Heart J. 2011.Important study
challenging the current paradigm derived from pathology studies
by determining the in vivo thresholds of fibrous cap thickness for
predicting plaque rupture.
20. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of
coronary atherosclerotic plaque by use of optical coherence
tomography. Circulation. 2005;111(12):1551–5.
21. ••Tanaka A, Imanishi T, Kitabata H, et al. Morphology of
exertion-triggered plaque rupture in patients with acute coronary
syndrome: an optical coherence tomography study. Circulation.
2008;118(23):2368–2373.Fibrous cap rupture can occur at sites
with different thickness depending on the trigger stimulus. This
observation challenges the current practice of just searching for
the thinnest part of the cap, and praises the need for a more
comprehensive and volumetric analysis of this complex structure.
22. •Ino Y, Kubo T, Tanaka A, et al. Difference of Culprit Lesion
Morphologies Between ST-Segment Elevation Myocardial Infarc-
tion and Non-ST-Segment Elevation Acute Coronary Syndrome
An Optical Coherence Tomography Study. JACC Cardiovasc
Interv. 2011;4(1):76–82.This study highlights the importance of
studying the morphology of fibrous caps. The authors suggest that
beyond the determination of fibrous cap dimensions, careful
analysis of its longitudinal morphology can relate to clinical
presentation in ACS patients.
23. Rathore S, Terashima M, Matsuo H, et al. In-vivo detection of the
frequency and distribution of thin-cap fibroatheroma and ruptured
plaques in patients with coronary artery disease: an optical
coherence tomographic study. Coron Artery Dis. 2011;22(2):64–
72.
24. Tanaka A, Imanishi T, Kitabata H, et al. Distribution and
frequency of thin-capped fibroatheromas and ruptured plaques in
the entire culprit coronary artery in patients with acute coronary
syndrome as determined by optical coherence tomography. Am J
Cardiol. 2008;102(8):975–9.
25. Sawada T, Shite J, Garcia-Garcia HM, et al. Feasibility of
combined use of intravascular ultrasound radiofrequency data
analysis and optical coherence tomography for detecting thin-cap
fibroatheroma. Eur Heart J. 2008;29(9):1136–46.
26. Libby P, Simon DI. Inflammation and thrombosis: the clot
thickens. Circulation. 2001;103(13):1718–20.
27. Libby P. Current concepts of the pathogenesis of the acute
coronary syndromes. Circulation. 2001;104(3):365–72.
28. Lendon CL, Davies MJ, Born GV, Richardson PD. Atheroscle-
rotic plaque caps are locally weakened when macrophages density
is increased. Atherosclerosis. 1991;87(1):87–90.
29. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in
acute coronary syndromes. Implications for plaque rupture.
Circulation. 1994;90(2):775–8.
30. Tearney GJ, Yabushita H, Houser SL, et al. Quantification of
macrophage content in atherosclerotic plaques by optical coher-
ence tomography. Circulation. 2003;107(1):113–9.
31. Tanaka A, Tearney GJ, Bouma BE. Challenges on the frontier of
intracoronary imaging: atherosclerotic plaque macrophage mea-
surement by optical coherence tomography. J Biomed Opt.
2010;15(1):011104.
32. Tearney GJ, Jang IK, Bouma BE. Optical coherence tomography
for imaging the vulnerable plaque. J Biomed Opt. 2006;11
(2):021002.
33. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal
plaque macrophage distributions in patients with acute and stable
presentations of coronary artery disease. J Am Coll Cardiol.
2004;44(5):972–9.
34. Raffel OC, Tearney GJ, Gauthier DD, et al. Relationship
between a systemic inflammatory marker, plaque inflammation,
and plaque characteristics determined by intravascular optical
coherence tomography. Arterioscler Thromb Vasc Biol.
2007;27(8):1820–7.
35. •Ferrante G, Nakano M, Prati F, et al. High levels of systemic
myeloperoxidase are associated with coronary plaque erosion in
patients with acute coronary syndromes: a clinicopathological
study. Circulation. 2010;122(24):2505–2513.Study associating
systemic elevation in selective inflammatory biomarkers with
specific pathologic alterations of the fibrous cap.
36. Garcia-Garcia HM, Costa MA, Serruys PW. Imaging of coronary
atherosclerosis: intravascular ultrasound. Eur Heart J. 2010;31
(20):2456–69.
37. Kaneda H, Ako J, Terashima M. Intravascular ultrasound imaging
for assessing regression and progression in coronary artery
disease. Am J Cardiol. 2010;106(12):1735–46.
282 Curr Cardiovasc Imaging Rep (2011) 4:276–283
38. Chia S, Raffel OC, Takano M, et al. Association of statin therapy
with reduced coronary plaque rupture: an optical coherence
tomography study. Coron Artery Dis. 2008;19(4):237–42.
39. ••Takarada S, Imanishi T, Kubo T, et al. Effect of statin therapy on
coronary fibrous-cap thickness in patients with acute coronary
syndrome: assessment by optical coherence tomography study.
Atherosclerosis. 2009;202(2):491–497.This study demonstrates
the potential of OCT for serially assessing structural changes in
the fibrous cap in response to a specific therapy.
40. Ambrose JA. In search of the “vulnerable plaque”: can it be
localized and will focal regional therapy ever be an option for
cardiac prevention? J Am Coll Cardiol. 2008;51(16):1539–42.
41. Stone GW,Maehara A, Lansky AJ, et al. A prospective natural-history
study of coronary atherosclerosis. N Engl JMed. 2011;364(3):226–35.
42. Nadkarni SK, Pierce MC, Park BH, et al. Measurement of
collagen and smooth muscle cell content in atherosclerotic plaques
using polarization-sensitive optical coherence tomography. J Am
Coll Cardiol. 2007;49(13):1474–81.
Curr Cardiovasc Imaging Rep (2011) 4:276–283 283
